296 related articles for article (PubMed ID: 34237649)
21. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy.
Salvarani C; Macchioni P; Zizzi F; Mantovani W; Rossi F; Castri C; Capozzoli N; Baricchi R; Boiardi L; Chiaravalloti F
Arthritis Rheum; 1991 Mar; 34(3):351-6. PubMed ID: 2003856
[TBL] [Abstract][Full Text] [Related]
22. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
23. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica.
van Sleen Y; Boots AMH; Abdulahad WH; Bijzet J; Sandovici M; van der Geest KSM; Brouwer E
Rheumatology (Oxford); 2020 Jan; 59(1):176-184. PubMed ID: 31292652
[TBL] [Abstract][Full Text] [Related]
24. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
25. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
26. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis.
Álvarez Rodríguez L; López-Hoyos M; Mata C; Fontalba A; Calvo Alen J; Marín MJ; Fernández-Luna JL; Aguero Balbín J; Aranzamendi Zaldunbide M; Blanco R; Martínez-Taboada VM
Ann Rheum Dis; 2011 Sep; 70(9):1677-83. PubMed ID: 21670089
[TBL] [Abstract][Full Text] [Related]
27. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the B cell repertoire against autoantigens in patients with giant cell arteritis and polymyalgia rheumatica.
Schmits R; Kubuschok B; Schuster S; Preuss KD; Pfreundschuh M
Clin Exp Immunol; 2002 Feb; 127(2):379-85. PubMed ID: 11876765
[TBL] [Abstract][Full Text] [Related]
29. [Giant cell arteritis and polymyalgia rheumatica: diagnostic criteria].
Marie I
Rev Med Interne; 2013 Jul; 34(7):403-11. PubMed ID: 23498714
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
[TBL] [Abstract][Full Text] [Related]
31. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
[TBL] [Abstract][Full Text] [Related]
33. Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica.
Zhang Y; Wang D; Chu X; Zhang W; Zeng X
Ir J Med Sci; 2019 May; 188(2):713-720. PubMed ID: 30251177
[TBL] [Abstract][Full Text] [Related]
34. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
35. Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
Liozon E; de Boysson H; Dalmay F; Gondran G; Bezanahary H; Fauchais AL; Ly KH
J Rheumatol; 2018 May; 45(5):678-685. PubMed ID: 29545449
[TBL] [Abstract][Full Text] [Related]
36. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.
Richardson JE; Gladman DD; Fam A; Keystone EC
Arthritis Rheum; 1987 Nov; 30(11):1293-7. PubMed ID: 3500727
[TBL] [Abstract][Full Text] [Related]
37. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
[TBL] [Abstract][Full Text] [Related]
39. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
40. Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis.
van Sleen Y; Wang Q; van der Geest KSM; Westra J; Abdulahad WH; Heeringa P; Boots AMH; Brouwer E
Sci Rep; 2017 Jul; 7(1):6553. PubMed ID: 28747747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
